Page 36 - Christiana Care Focus October 2018

Pharmacy Services |
Medication – Generic/Brand Name
Angiotensin II Injection/Giapreza
Buprenorphine Extended-Release Injection/Sublocade
Dantrolene Injection/ Ryanodex
Heparin Injection
Ketamine Injection
Lithium Carbonate Capsule
Lithium Carbonate Tablet
Methotrexate Tablet
Morphine Injection
Nalbuphine Injection
Nivolumab Injection/Opdivo
Rabies Immune Globulin Injection
Betamethasone lotions
Buprenorphine Extended-Release Subcutaneous Implant/Probuphine
Flucytosine suspension Magnesium Sulfate Injection
Mechlorethamine injection
Pralatrexate Injection 20 mg vials
Rabies Immune Globulin Injection 300 units/2 mL
Strength/Size
2.5 mg/mL 1-mL vial
100 mg/0.5 mL 100 mg & 300 mg prefilled syringes
250 mg vial
1000 units/mL 2000 units/ vial
50 mg/mL 500 mg/vial
150 mg Immediate-Release
300 mg Sustained-Release
10 mg
50 mg/mL 1000 mg/vial
10 mg/mL
1 mL ampule
10 mg/mL 240 mg/vial
300 units/mL 1-mL vial
Use/Indication
To increase blood pressure in adults with septic or other disruptive shock
Treatment of opioid use disorder
Management of malignant hyperthermia
Anticoagulation
Anesthesia, analgesia, sedation & treatment of depression and status epilepticus
Treatment of bipolar disorder, depression & traumatic brain injury
Treatment of bipolar disorder, depression & traumatic brain injury
Treatment of cancer, psoriasis & rheumatoid arthritis
Analgesia
Analgesia
Treatment of several types of cancer
Post rabies exposure prophylaxis
Comment
•Critical care attending physician must approve patient order
• Administration limited to patients with resistant hypotension despite concomitant administration of 2 or more vasopressors
•Dispensed only to a qualified health care provider for administration by the provider
•Availability limited to Christiana Care- owned office practices
Line item extension
Line item extension
Line item extension
Line item extension
Line item extension
Line item extension
Line item extension
Line item extension
Line item extension
Line item extension
Removed because of lack of use
Replaced with buprenorphine extended-release subcutaneous Injection (Sublocade)
Compounding of suspension formulation discontinued
IV bags containing 6 grams of magnesium sulfate removed from formulary because of change in process. The initial 6 gram bolus infusion will be delivered from an IV bag containing 20 grams of magnesium sulfate
Removed because of lack of use
40 mg vials remain on the formulary
Product discontinued and replaced with a 300 units/mL product
34 CHRISTIANA CARE HEALTH SYSTEM
CONTINUED
Formulary Update | August 2018
ADDITIONS DELETIONS